← Back to Discover
Invus Financial Advisors, LLC
Period ended Jun 30, 2024 · Latest filing Aug 14, 2024
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2024: $89,240,348
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2024. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- Taboola.com Ltd · ORD SHS · M8744T106 · shares: $34,295,063
- Arcus Biosciences Inc · COM · 03969F109 · shares: $24,551,933
- IHS Holding Limited · ORD SHS · G4701H109 · shares: $7,544,064
- Oric Pharmaceuticals Inc · COM · 68622P109 · shares: $7,123,555
- Coupang Inc · CL A · 22266T109 · shares: $6,200,090
- Novocure Ltd · ORD SHS · G6674U108 · shares: $6,010,643
- IONQ Inc · COM · 46222L108 · shares: $3,515,000
Reported holdings
7 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| Taboola.com Ltd | ORD SHS | M8744T106 | — | 9,969,495 shares | $34,295,063 |
| Arcus Biosciences Inc | COM | 03969F109 | — | 1,612,077 shares | $24,551,933 |
| IHS Holding Limited | ORD SHS | G4701H109 | — | 2,357,520 shares | $7,544,064 |
| Oric Pharmaceuticals Inc | COM | 68622P109 | — | 1,007,575 shares | $7,123,555 |
| Coupang Inc | CL A | 22266T109 | — | 295,947 shares | $6,200,090 |
| Novocure Ltd | ORD SHS | G6674U108 | — | 350,884 shares | $6,010,643 |
| IONQ Inc | COM | 46222L108 | — | 500,000 shares | $3,515,000 |